AN-2718

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameAN-2718
Drug Alias NameAN-2718
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucyl-tRNA synthetase inhibitors
TargetsLeucyl-tRNA synthetase
Therapy Area/IndicationsTinea Pedis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsTinea Pedis

Other Information

ATC CodeN/A
Related LinksN/A